US Patent Issued to INVENTISBIO on Sept. 29 for "Oral formulations and uses thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,229, issued on Sept. 29, was assigned to INVENTISBIO Co. LTD. (Shanghai).

"Oral formulations and uses thereof" was invented by Xing Dai (Short Hills, N.J.), Xiaomei Wang (Shanghai), Yanqin Liu (Shanghai), Yueheng Jiang (Shanghai) and Yaolin Wang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds, salts, crystalline forms, and pharmaceutical compositions that are related to Selective Estrogen Receptor Degraders, as well as methods of preparing the same. Also provided herein are methods of using the compounds, salts, crystalline forms, and pharmaceutical compositions for the treatment of diseases or disorders, such...